Johan A. van Zyl
Geen lopende functies
Profiel
Johan A.
van Zyl served as a Director-Supervisory Board at Bac BV.
Prior to that, he worked as a Deal Manager at Stonehage Fleming Private Equity Ltd.
from 2001 to 2009.
He completed his undergraduate degree from the University of Stellenbosch.
Eerdere bekende functies van Johan A. van Zyl
| Bedrijven | Functie | Einde |
|---|---|---|
Stonehage Fleming Private Equity Ltd.
 Stonehage Fleming Private Equity Ltd. Investment ManagersFinance Stonehage Fleming Private Equity Ltd (Stonehage Fleming Private Equity) is a private equity subsidiary of Stonehage Fleming (UK) Ltd founded in 2000. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01-12-2009 |
BAC BV
 BAC BV Industrial MachineryProducer Manufacturing BAC BV discovers, develops and manufactures affinity ligands and affinity purification products for the biopharmaceutical market. Its CaptureSelect products are used for drug discovery up to manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids. The company was founded in 1995 and is headquartered in Amsterdam, the Netherlands. | Directeur/Bestuurslid | - |
Opleiding van Johan A. van Zyl
| University of Stellenbosch | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Stonehage Fleming Private Equity Ltd.
Stonehage Fleming Private Equity Ltd. Investment ManagersFinance Stonehage Fleming Private Equity Ltd (Stonehage Fleming Private Equity) is a private equity subsidiary of Stonehage Fleming (UK) Ltd founded in 2000. The firm is headquartered in London, United Kingdom. | Finance |
BAC BV
BAC BV Industrial MachineryProducer Manufacturing BAC BV discovers, develops and manufactures affinity ligands and affinity purification products for the biopharmaceutical market. Its CaptureSelect products are used for drug discovery up to manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids. The company was founded in 1995 and is headquartered in Amsterdam, the Netherlands. | Producer Manufacturing |
